MATTEO, C., Gabriela PŘIBYL DOVRTĚLOVÁ, A. DI CLEMENTE, R. FRAPOLLI, A. PASSONI, T. CERUTI, G. MARSELLA, L. CERVO a M. ZUCCHETTI. HPLC-MS/MS measurement of lidocaine in rat skin and plasma. Application to study the release from medicated plaster. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. Amsterdam: Elsevier, roč. 1138, FEB 2020, s. 1-8. ISSN 1570-0232. doi:10.1016/j.jchromb.2019.121942. 2020.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název HPLC-MS/MS measurement of lidocaine in rat skin and plasma. Application to study the release from medicated plaster
Autoři MATTEO, C. (380 Itálie), Gabriela PŘIBYL DOVRTĚLOVÁ (203 Česká republika, garant, domácí), A. DI CLEMENTE (380 Itálie), R. FRAPOLLI (380 Itálie), A. PASSONI (380 Itálie), T. CERUTI (380 Itálie), G. MARSELLA (380 Itálie), L. CERVO (380 Itálie) a M. ZUCCHETTI (380 Itálie).
Vydání Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Amsterdam, Elsevier, 2020, 1570-0232.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 10406 Analytical chemistry
Stát vydavatele Nizozemské království
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 3.205
Kód RIV RIV/00216224:14310/20:00115466
Organizační jednotka Přírodovědecká fakulta
Doi http://dx.doi.org/10.1016/j.jchromb.2019.121942
UT WoS 000510111600002
Klíčová slova anglicky Lidocaine; HPLC-MS/MS analysis; Skin; Pharmacokinetics; Medicated plaster
Štítky rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Marie Šípková, DiS., učo 437722. Změněno: 23. 11. 2020 10:32.
Anotace
A simple, sensitive HPLC-MS/MS method was developed and validated for the determination of lidocaine in skin and plasma of rats. The methods were established and validated assessing lower limit of quantitation (LLOQ), linearity, intra and inter-day precision and accuracy, selectivity, recovery and matrix effect. Chromatography was done on a Gemini column embedded with C18 stationary phase (50 mm x 2.0 mm, 5 mu m particle size), using a gradient with mobile phases consisting of 0.1% HCOOH in bidistilled water and 0.1% HCOOH in acetonitrile. The mass spectrometer worked with electrospray ionization in positive ion mode and selected reaction monitoring, using target ions m/z 235.10 for lidocaine and m/z 245.10 for lidocaine-d10, used as internal standard. Results: The linearity of the method was in the ranges of lidocaine concentrations 10.0-200.0 ng/mL for skin homogenate (accuracy 94.1-105.5%; R-2 >= 0.998) and 0.025-2 ng/mL for plasma (accuracy 96.2-104.8%; R-2 >= 0.996). The intra- and inter-day precision and accuracy determined on three quality control samples (20, 75 and 170 ng/mL for skin and 0.075, 0.4 and 1.5 ng/mL for plasma) were <= 4.2% and 103.8-108.2% for skin and <= 12.4% and 95.5-101.4% for plasma. The LLOQ was 10 ng/mL in skin homogenate and 0.025 ng/mL in plasma. The applicability of the method was demonstrated by measuring lidocaine in skin and plasma after exposure to medicated patches containing 5% lidocaine.
VytisknoutZobrazeno: 19. 4. 2024 15:45